Changes in ATP13A2 mRNA and protein levels have been detected in dopaminergic SN neurons of sPD patients [70,130,131], further supporting the involvement of ATP13A2 in sporadic forms of PD. This evidence concerns the gene ATP13A2 and Parkinson disease.